Immunome, Inc. (IMNM)
NASDAQ: IMNM · IEX Real-Time Price · USD
13.83
-0.57 (-3.96%)
At close: May 17, 2024, 4:00 PM
13.84
+0.01 (0.07%)
After-hours: May 17, 2024, 7:48 PM EDT
Immunome Market Cap
Immunome has a market cap or net worth of $828.17 million as of May 17, 2024. Its market cap has increased by 965.86% in one year.
Market Cap
828.17M
Enterprise Value
519.57M
1-Year Change
965.86%
Ranking
Category
Stock Price
$13.83
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $828.17M, an increase of 643.48%. That is a compound annual growth rate of 73.93%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 829.40M | -3.96% |
May 16, 2024 | 863.60M | -2.69% |
May 15, 2024 | 887.50M | 0.54% |
May 14, 2024 | 882.70M | -5.27% |
May 13, 2024 | 931.80M | 0.70% |
May 10, 2024 | 925.30M | 0.13% |
May 9, 2024 | 924.10M | -1.40% |
May 8, 2024 | 937.20M | 2.42% |
May 7, 2024 | 915.10M | -0.85% |
May 6, 2024 | 922.90M | -1.84% |
May 3, 2024 | 940.20M | 5.21% |
May 2, 2024 | 893.60M | 1.90% |
May 1, 2024 | 876.90M | 4.48% |
Apr 30, 2024 | 839.30M | 1.73% |
Apr 29, 2024 | 825.00M | 0.66% |
Apr 26, 2024 | 819.60M | -3.71% |
Apr 25, 2024 | 851.20M | -0.07% |
Apr 24, 2024 | 851.80M | -2.66% |
Apr 23, 2024 | 875.10M | -4.06% |
Apr 22, 2024 | 912.10M | -1.30% |
Apr 19, 2024 | 924.10M | -9.89% |
Apr 18, 2024 | 1.03B | -1.16% |
Apr 17, 2024 | 1.04B | -5.54% |
Apr 16, 2024 | 1.10B | -2.38% |
Apr 15, 2024 | 1.13B | -8.41% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
89bio | 850.04M |
Mesoblast | 838.81M |
Embecta | 835.64M |
Atrion | 833.93M |
HealthStream | 831.69M |
Aurinia Pharmaceuticals | 825.22M |
Canopy Growth | 823.95M |
Nuvation Bio | 820.61M |